Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AptarGroup, Inc. Common Stock
(NY:
ATR
)
137.20
+6.56 (+5.02%)
Official Closing Price
Updated: 6:30 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AptarGroup, Inc. Common Stock
< Previous
1
2
3
4
Next >
What AptarGroup (ATR) Said on Its Q3 Earnings Call
↗
Today 12:15 EDT
AptarGroup (NYSE:ATR) reported third-quarter 2026 sales growth across its three business segments, while adjusted profitability declined from the prior year as emergency medicine destocking and lower...
Via
MarketBeat
Topics
Earnings
AptarGroup (NYSE:ATR) Q3 2026: Revenue and EPS Beat, But Margin Pressure and Russia Charge Weigh on Reaction
↗
October 29, 2026
Via
Chartmill
Aptar (ATR) Q2 2026 Earnings Call Transcript
↗
August 07, 2026
Record $1B revenue as pharma growth offsets margin pressure.
Via
The Motley Fool
Topics
Earnings
AptarGroup Q2 Earnings Call Highlights
↗
July 31, 2026
AptarGroup (NYSE:ATR) reported second-quarter sales growth across each of its three segments and adjusted earnings per share above its guidance range, supported by stronger-than-expected performance in...
Via
MarketBeat
Topics
Earnings
AptarGroup (NYSE:ATR) Tops Q2 Estimates, Shares Rise After Hours
↗
July 30, 2026
Via
Chartmill
AptarGroup Q1 2026: Pharma Destocking Drags Earnings as Core Sales Stall for NYSE:ATR
↗
April 30, 2026
Via
Chartmill
AptarGroup Inc (NYSE:ATR) Beats Q4 Revenue Estimates, Issues Cautious Q1 Outlook
↗
February 05, 2026
Via
Chartmill
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
↗
May 09, 2026
AptarGroup (NYSE:ATR) used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and...
Via
MarketBeat
AptarGroup (ATR) Q1 2026 Earnings Transcript
↗
May 01, 2026
AptarGroup (ATR) Q1 2026 Earnings Transcript
Via
The Motley Fool
Boston Trust Walden Lets Go of 93,000 Qualys (QLYS) Shares
↗
April 26, 2026
Qualys delivers cloud-based security and compliance solutions to enterprise and public sector clients across multiple industries.
Via
The Motley Fool
Topics
Regulatory Compliance
Earnings Scheduled For October 30, 2025
↗
October 30, 2025
Via
Benzinga
Is the Market Bullish or Bearish on AptarGroup?
↗
August 27, 2025
Via
Benzinga
Earnings Scheduled For July 31, 2025
↗
July 31, 2025
Via
Benzinga
What to Expect from AptarGroup's Earnings
↗
July 30, 2025
Via
Benzinga
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
March 11, 2026
Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends...
Via
MarketMinute
Topics
Economy
Retirement
River Road Loads Up on ATR With 917,000 Shares in New Position
↗
February 28, 2026
AptarGroup delivers proprietary dispensing and sealing solutions to global healthcare, beauty, and consumer markets.
Via
The Motley Fool
Topics
Emissions
Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)
December 23, 2025
Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical...
Via
PredictStreet
Topics
Economy
Intellectual Property
Supply Chain
How Do Investors Really Feel About AptarGroup?
↗
July 28, 2025
Via
Benzinga
Top 3 Materials Stocks That May Rocket Higher In Q3
↗
September 24, 2025
Via
Benzinga
This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
September 04, 2025
Via
Benzinga
AptarGroup (ATR) Q2 2025 Earnings Call Transcript
↗
August 04, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
AptarGroup (ATR) Q2 Revenue Rises 6%
↗
August 01, 2025
Via
The Motley Fool
Topics
Economy
World Trade
Looking Into AptarGroup's Recent Short Interest
↗
July 07, 2025
Via
Benzinga
Peering Into AptarGroup's Recent Short Interest
↗
May 21, 2025
Via
Benzinga
Earnings Scheduled For May 1, 2025
↗
May 01, 2025
Via
Benzinga
$100 Invested In AptarGroup 20 Years Ago Would Be Worth This Much Today
↗
July 02, 2025
Via
Benzinga
Here's How Much You Would Have Made Owning AptarGroup Stock In The Last 20 Years
↗
June 19, 2025
Via
Benzinga
Here's How Much $100 Invested In AptarGroup 20 Years Ago Would Be Worth Today
↗
June 06, 2025
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
↗
April 03, 2025
Via
Benzinga
What's Driving the Market Sentiment Around AptarGroup?
↗
March 25, 2025
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
